Lazard Asset Management LLC Lexicon Pharmaceuticals, Inc. Transaction History

Lazard Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$1.05 - $3.67 $1.84 Million - $6.44 Million	-1,753,445 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.44 - $2.1 $1.44 Million - $2.09 Million	997,103 Added 131.83%	1,753,445 $2.52 Million
Q2 2020 Aug 13, 2020	BUY	$1.75 - $2.3 $1.32 Million - $1.74 Million	756,342 New	756,342 $1.51 Million
Q1 2020 May 14, 2020	SELL	$1.8 - $4.28 $10,080 - $23,968	-5,600 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$3.16 - $5.15 $17,696 - $28,840	5,600 New	5,600 $23,000
Q1 2019 May 13, 2019	SELL	$4.36 - $7.94 $197,072 - $358,888	-45,200 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$6.15 - $10.51 $628,431 - $1.07 Million	-102,184 Reduced 69.33%	45,200 $300,000
Q1 2016 Jul 25, 2019	BUY	N/A	21,426 Added 17.01%	147,384 $1.76 Million
Q4 2015 Jul 24, 2019	BUY	N/A	119,458 Added 1837.82%	125,958 $1.68 Million
Q3 2015 Jul 15, 2019	BUY	N/A	6,500	6,500 $69,000

139

244M

52K

178K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $121M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.